Table 1.
Baseline characteristics of patients who underwent EUS-radiofrequency ablation
| Characteristics | Total (n=22), n(%) | Locally advanced (n=14), n(%) | Metastatic (n=8), n(%) |
|---|---|---|---|
| Age (years), median (IQR) | 60.5 (56.25-68.75) | 60 (56.75-69.5) | 60.5 (56-69.75) |
| Sex (male:female) | 13:9 | 10:4 | 3:5 |
| Location | |||
| Head | 14 (63.6) | 11 (78.6) | 3 (37.5) |
| Body | 4 (18.2) | 2 (14.3) | 2 (25) |
| Tail | 3 (13.6) | 1 (7.1) | 2 (25) |
| Distal pancreatectomy resection margin | 1 (4.5) | 0 | 1 (12.5) |
| Tumor size (mm), median (IQR) | 38 (32.75-45) | 35 (27.25-45) | 41.5 (35.25-75) |
| Initial CA19-9 (U/mL), median (IQR) | 200.8 (15.9-901.3) | 47.9 (6.8-489.55) | 619.45 (76.7–3489.75) |
| CA19-9>200 U/mL | 11 (50) | 5 (35.7) | 6 (75) |
| Nodal metastasis | 16 (72.7) | 8 (57.1) | 8 (100) |
| Sequential chemotherapy | |||
| Before EUS-RFA | 19 (86.4) | 14 (100) | 5 (62.5) |
| After EUS-RFA | 3 (13.6) | 0 | 3 (37.5) |
| Induction chemotherapy | 18 (81.8) | 10 (71.4) | 8 (100) |
IQR: Interquartile range; EUS-RFA: EUS-radiofrequency ablation; CA: Celiac axis